Medicare Part D Drug Coverage List

According to the Centers for Medicare & Medicaid Services (CMS) 2026 Part D formulary data, this list covers 6,046 drugs across Medicare Part D plans, sorted by how broadly each is covered. Under the Inflation Reduction Act, Part D out-of-pocket costs are capped at $2,000 a year in 2026; see our methodology for how coverage breadth is calculated.

Coverage varies by plan and geography. Verify drug coverage with your specific plan before making decisions.
Drug Name Plans Covering Coverage % Avg Tier PA % 2023 Benes
albuterol 2 MG Oral Tablet
albuterol
4,642 91.6% T3 0% 1,487
nadolol 20 MG Oral Tablet
nadolol
4,639 91.6% T2 0% 65,690
nadolol 40 MG Oral Tablet
nadolol
4,639 91.6% T2 0% 65,690
nadolol 80 MG Oral Tablet
nadolol
4,639 91.6% T2 0% 65,690
1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML Injection
glucose
4,635 91.5% T3 4.6% -
netarsudil 0.2 MG/ML Ophthalmic Solution [Rhopressa]
netarsudil
4,632 91.4% T3 0.7% 89,044
metronidazole 7.5 MG/ML Topical Lotion
metronidazole
4,631 91.4% T3 0% 1,528,785
metformin hydrochloride 500 MG / pioglitazone 15 MG Oral Tablet
metformin hydrochloride
4,628 91.3% T3 0% 5,918,026
metformin hydrochloride 850 MG / pioglitazone 15 MG Oral Tablet
metformin hydrochloride
4,628 91.3% T3 0% 5,918,026
{28 (letrozole 2.5 MG Oral Tablet [Femara]) / 42 (ribociclib 200 MG Oral Tablet [Kisqali]) } Pack [Kisqali Femara Co-Pack 400]
letrozole
4,626 91.3% T4 99.3% 209
{28 (letrozole 2.5 MG Oral Tablet [Femara]) / 63 (ribociclib 200 MG Oral Tablet [Kisqali]) } Pack [Kisqali Femara Co-Pack 600]
letrozole
4,626 91.3% T4 99.3% 209
4 ML bumetanide 0.25 MG/ML Injection
bumetanide
4,626 91.3% T3 0.8% -
sofosbuvir 400 MG / velpatasvir 100 MG / voxilaprevir 100 MG Oral Tablet [Vosevi]
sofosbuvir
4,620 91.2% T4 99.7% 18
hydrochlorothiazide 25 MG / metoprolol tartrate 100 MG Oral Tablet
hydrochlorothiazide
4,618 91.1% T2 0% 4,902,174
{21 (drospirenone 3 MG / ethinyl estradiol 0.03 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack
drospirenone
4,615 91.1% T2 0% -
{24 (drospirenone 3 MG / ethinyl estradiol 0.02 MG Oral Tablet) / 4 (inert ingredients 1 MG Oral Tablet) } Pack [Vestura]
drospirenone
4,614 91.1% T2 0% 406
hydrochlorothiazide 50 MG / metoprolol tartrate 100 MG Oral Tablet
hydrochlorothiazide
4,612 91% T2 0% 4,902,174
1 ML guselkumab 100 MG/ML Prefilled Syringe [Tremfya]
guselkumab
4,612 91% T4 99.3% 8,945
1 ML guselkumab 100 MG/ML Auto-Injector [Tremfya]
guselkumab
4,612 91% T4 99.3% 8,945
2 ML guselkumab 100 MG/ML Auto-Injector [Tremfya]
guselkumab
4,612 91% T4 99.3% 8,945
{2 (2 ML guselkumab 100 MG/ML Auto-Injector [Tremfya]) } Pack [Tremfya Induction Pack for Crohn's Disease]
guselkumab
4,612 91% T4 99.3% 8,945
2 ML guselkumab 100 MG/ML Prefilled Syringe [Tremfya]
guselkumab
4,612 91% T4 99.3% 8,945
{7 (desogestrel 0.1 MG / ethinyl estradiol 0.025 MG Oral Tablet) / 7 (desogestrel 0.125 MG / ethinyl estradiol 0.025 MG Oral Tablet) / 7 (desogestrel 0.15 MG / ethinyl estradiol 0.025 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Velivet 28 Day]
desogestrel
4,612 91% T2 0% -
{24 (drospirenone 3 MG / ethinyl estradiol 0.02 MG Oral Tablet) / 4 (inert ingredients 1 MG Oral Tablet) } Pack [Jasmiel 28 Day]
drospirenone
4,606 90.9% T2 0% -
cefprozil 25 MG/ML Oral Suspension
cefprozil
4,605 90.9% T2 0% 22,839
cefprozil 50 MG/ML Oral Suspension
cefprozil
4,605 90.9% T2 0% 22,839
amlodipine 5 MG / olmesartan medoxomil 20 MG Oral Tablet
amlodipine
4,597 90.7% T2 0% 11,575,402
amlodipine 10 MG / olmesartan medoxomil 20 MG Oral Tablet
amlodipine
4,597 90.7% T2 0% 11,575,402
amlodipine 5 MG / olmesartan medoxomil 40 MG Oral Tablet
amlodipine
4,597 90.7% T2 0% 11,575,402
amlodipine 10 MG / olmesartan medoxomil 40 MG Oral Tablet
amlodipine
4,597 90.7% T2 0% 11,575,402
168 HR ethinyl estradiol 0.00146 MG/HR / norelgestromin 0.00625 MG/HR Transdermal System [Xulane]
ethinyl estradiol
4,593 90.6% T2 0% 1,329
1 ML benralizumab 30 MG/ML Auto-Injector [Fasenra]
benralizumab
4,591 90.6% T4 100% 2,747
C1 esterase inhibitor (human) 2000 UNT Injection [Haegarda]
C1
4,589 90.6% T4 99.3% 191
C1 esterase inhibitor (human) 3000 UNT Injection [Haegarda]
C1
4,589 90.6% T4 99.3% 191
linagliptin 5 MG Oral Tablet [Tradjenta]
linagliptin
4,588 90.5% T3 0.3% 286,808
{7 (ethinyl estradiol 0.025 MG / norgestimate 0.18 MG Oral Tablet) / 7 (ethinyl estradiol 0.025 MG / norgestimate 0.215 MG Oral Tablet) / 7 (ethinyl estradiol 0.025 MG / norgestimate 0.25 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Tri-Lo- Estarylla 28 Day]
ethinyl estradiol
4,588 90.5% T2 0% -
1 ML evolocumab 140 MG/ML Prefilled Syringe [Repatha]
evolocumab
4,587 90.5% T3 79.9% -
{7 (ethinyl estradiol 0.025 MG / norgestimate 0.18 MG Oral Tablet) / 7 (ethinyl estradiol 0.025 MG / norgestimate 0.215 MG Oral Tablet) / 7 (ethinyl estradiol 0.025 MG / norgestimate 0.25 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack
ethinyl estradiol
4,573 90.3% T2 0% -
alanine 5.4 MG/ML / arginine 12 MG/ML / aspartate 3.2 MG/ML / cysteine 0.24 MG/ML / glutamate 5 MG/ML / glycine 3.6 MG/ML / histidine 4.8 MG/ML / isoleucine 8.2 MG/ML / leucine 1.4 MG/ML / lysine 1.2 MG/ML / methionine 3.4 MG/ML / phenylalanine 4.8 MG/ML / proline 6.8 MG/ML / serine 3.8 MG/ML / sodium acetate 0.097 MEQ/ML / sodium chloride 0.003 MEQ/ML / sodium metabisulfite 0.5 MG/ML / taurine 0.25 MG/ML / threonine 4.2 MG/ML / tryptophan 2 MG/ML / tyrosine 2.84 MG/ML / valine 7.8 MG/ML Injectable Solution [Trophamine 10 %]
alanine
4,572 90.2% T3 98.1% -
dexmethylphenidate hydrochloride 2.5 MG Oral Tablet
dexmethylphenidate hydrochloride
4,569 90.2% T2 38.9% 9,197
dexmethylphenidate hydrochloride 5 MG Oral Tablet
dexmethylphenidate hydrochloride
4,569 90.2% T2 38.9% 9,197
dexmethylphenidate hydrochloride 10 MG Oral Tablet
dexmethylphenidate hydrochloride
4,569 90.2% T2 38.9% 9,197
ganciclovir 0.0015 MG/MG Ophthalmic Gel [Zirgan]
ganciclovir
4,566 90.1% T3 0% 11,222
cobicistat 150 MG Oral Tablet [Tybost]
cobicistat
4,563 90.1% T3 0% 149
24 HR clarithromycin 500 MG Extended Release Oral Tablet
clarithromycin
4,563 90.1% T3 0% -
estrogens, conjugated (USP) 0.625 MG/ML Vaginal Cream [Premarin]
estrogens,
4,560 90% T3 0% 241,518
travoprost 0.04 MG/ML Ophthalmic Solution
travoprost
4,558 90% T3 0.4% 123,672
{84 (ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Iclevia 91 Day]
ethinyl estradiol
4,558 90% T2 0% -
1.5 ML insulin glargine 300 UNT/ML Pen Injector [Toujeo]
insulin glargine
4,554 89.9% T3 0% -
3 ML insulin glargine 300 UNT/ML Pen Injector [Toujeo]
insulin glargine
4,554 89.9% T3 0% -
methadone hydrochloride 1 MG/ML Oral Solution
methadone hydrochloride
4,550 89.8% T2 43.4% 68,081
erythromycin 333 MG Delayed Release Oral Tablet
erythromycin
4,550 89.8% T3 0% 1,861
erythromycin 500 MG Delayed Release Oral Tablet
erythromycin
4,542 89.6% T3 0% 1,861
1000 ML glucose 25 MG/ML / sodium chloride 4.5 MG/ML Injection
glucose
4,536 89.5% T3 0.8% -
latanoprost 0.05 MG/ML / netarsudil 0.2 MG/ML Ophthalmic Solution [Rocklatan]
latanoprost
4,535 89.5% T3 0.7% 2,403,493
{7 (ethinyl estradiol 0.035 MG / norgestimate 0.18 MG Oral Tablet) / 7 (ethinyl estradiol 0.035 MG / norgestimate 0.215 MG Oral Tablet) / 7 (ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Tri-Mili 28 Day]
ethinyl estradiol
4,535 89.5% T2 0% -
candesartan cilexetil 16 MG / hydrochlorothiazide 12.5 MG Oral Tablet
candesartan cilexetil
4,530 89.4% T3 0% 109,771
candesartan cilexetil 32 MG / hydrochlorothiazide 12.5 MG Oral Tablet
candesartan cilexetil
4,530 89.4% T3 0% 109,771
candesartan cilexetil 32 MG / hydrochlorothiazide 25 MG Oral Tablet
candesartan cilexetil
4,530 89.4% T3 0% 109,771
piroxicam 10 MG Oral Capsule
piroxicam
4,530 89.4% T2 0% 17,658
piroxicam 20 MG Oral Capsule
piroxicam
4,530 89.4% T2 0% 17,658
{21 (ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [VyLibra 28 Day]
ethinyl estradiol
4,530 89.4% T2 0% -
penicillin G sodium 100000 UNT/ML Injectable Solution
penicillin G sodium
4,525 89.3% T3 10% 53
levothyroxine sodium 0.025 MG Oral Tablet [Unithroid]
levothyroxine sodium
4,521 89.2% T2 0% 8,687,969
levothyroxine sodium 0.05 MG Oral Tablet [Unithroid]
levothyroxine sodium
4,521 89.2% T2 0% 8,687,969
levothyroxine sodium 0.075 MG Oral Tablet [Unithroid]
levothyroxine sodium
4,521 89.2% T2 0% 8,687,969
levothyroxine sodium 0.088 MG Oral Tablet [Unithroid]
levothyroxine sodium
4,521 89.2% T2 0% 8,687,969
levothyroxine sodium 0.1 MG Oral Tablet [Unithroid]
levothyroxine sodium
4,521 89.2% T2 0% 8,687,969
levothyroxine sodium 0.112 MG Oral Tablet [Unithroid]
levothyroxine sodium
4,521 89.2% T2 0% 8,687,969
levothyroxine sodium 0.125 MG Oral Tablet [Unithroid]
levothyroxine sodium
4,521 89.2% T2 0% 8,687,969
levothyroxine sodium 0.137 MG Oral Tablet [Unithroid]
levothyroxine sodium
4,521 89.2% T2 0% 8,687,969
levothyroxine sodium 0.15 MG Oral Tablet [Unithroid]
levothyroxine sodium
4,521 89.2% T2 0% 8,687,969
levothyroxine sodium 0.175 MG Oral Tablet [Unithroid]
levothyroxine sodium
4,521 89.2% T2 0% 8,687,969
levothyroxine sodium 0.2 MG Oral Tablet [Unithroid]
levothyroxine sodium
4,521 89.2% T2 0% 8,687,969
levothyroxine sodium 0.3 MG Oral Tablet [Unithroid]
levothyroxine sodium
4,521 89.2% T2 0% 8,687,969
{7 (ethinyl estradiol 0.035 MG / norgestimate 0.18 MG Oral Tablet) / 7 (ethinyl estradiol 0.035 MG / norgestimate 0.215 MG Oral Tablet) / 7 (ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Tri-VyLibra 28 Day]
ethinyl estradiol
4,519 89.2% T2 0% -
60 ACTUAT fluticasone propionate 0.1 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler [Wixela] 4,505 88.9% T2 0% -
60 ACTUAT fluticasone propionate 0.25 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler [Wixela] 4,505 88.9% T2 0% -
60 ACTUAT fluticasone propionate 0.5 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler [Wixela] 4,505 88.9% T2 0% -
rimantadine hydrochloride 100 MG Oral Tablet
rimantadine hydrochloride
4,504 88.9% T3 0% 230
lamotrigine 150 MG Oral Tablet [Subvenite]
lamotrigine
4,501 88.8% T1 0% 611,083
lamotrigine 25 MG Oral Tablet [Subvenite]
lamotrigine
4,501 88.8% T1 0% 611,083
lamotrigine 100 MG Oral Tablet [Subvenite]
lamotrigine
4,501 88.8% T1 0% 611,083
lamotrigine 200 MG Oral Tablet [Subvenite]
lamotrigine
4,501 88.8% T1 0% 611,083
deutetrabenazine 6 MG Oral Tablet [Austedo]
deutetrabenazine
4,495 88.7% T4 99.7% 18,283
deutetrabenazine 9 MG Oral Tablet [Austedo]
deutetrabenazine
4,495 88.7% T4 99.7% 18,283
deutetrabenazine 12 MG Oral Tablet [Austedo]
deutetrabenazine
4,495 88.7% T4 99.7% 18,283
cyclophosphamide 50 MG Oral Tablet
cyclophosphamide
4,495 88.7% T3 100% 1,621
trospium chloride 20 MG Oral Tablet
trospium chloride
4,494 88.7% T2 0.7% 114,171
8 HR methylphenidate hydrochloride 10 MG Extended Release Oral Tablet
methylphenidate hydrochloride
4,494 88.7% T3 40.9% -
{21 (ethinyl estradiol 0.035 MG / norethindrone 1 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Nylia 1/35 28 Day]
ethinyl estradiol
4,492 88.7% T2 0% -
ampicillin 2000 MG Injection
ampicillin
4,489 88.6% T3 11.6% 3,864
{7 (ethinyl estradiol 0.035 MG / norethindrone 0.5 MG Oral Tablet) / 7 (ethinyl estradiol 0.035 MG / norethindrone 0.75 MG Oral Tablet) / 7 (ethinyl estradiol 0.035 MG / norethindrone 1 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Nylia 7/7/7 28 Day]
ethinyl estradiol
4,484 88.5% T2 0% -
2.4 ML aripiprazole 300 MG/ML Prefilled Syringe [Abilify]
aripiprazole
4,481 88.4% T4 2.4% 1,736
3.2 ML aripiprazole 300 MG/ML Prefilled Syringe [Abilify]
aripiprazole
4,481 88.4% T4 2.4% 1,736
mesalamine 1000 MG Rectal Suppository
mesalamine
4,477 88.4% T3 0% 95,185
hydrocortisone 0.01 MG/MG Topical Ointment
hydrocortisone
4,474 88.3% T2 0% 1,257,661
isotretinoin 10 MG Oral Capsule [Accutane]
isotretinoin
4,471 88.2% T3 45.9% 2,097
{21 (ethinyl estradiol 0.05 MG / ethynodiol diacetate 1 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Valtya 1/50 28 Day]
ethinyl estradiol
4,471 88.2% T2 0% -
Pulmonary Hypertension tadalafil 20 MG Oral Tablet
Pulmonary Hypertension tadalafil
4,470 88.2% T3 100% -
← Previous Page 27 of 61 Next →

Source: CMS Quarterly Prescription Drug Plan Formulary PUF 2026. 6,046 drugs with RXCUI identifiers from NLM RxNorm. Coverage percentages based on 0 active Part D plans.